Healthcare
Arcano holds EUR 280m final close for impact fund-of-funds
Spanish GP is eyeing a second vintage in 2023 with the vehicle more than 50% deployed
AG Capital kicks off inaugural fund with Improove buyout
Austrian emerging manager acquires local SEO agency with country's first buyout fund in a decade
Permira announces changes in DACH leadership
Jörg Rockenhäuser to become region’s first chairman as Florian Kreuzer succeeds him as head of DACH
FSI eyes new fund with near EUR 1bn returned to LPs this year
Italian GP conducted three exits in 2022; Fund II would have similar size as EUR 1.4bn predecessor
Women in VC: Speedinvest's Nangia on supporting female and underrepresented founders
Austrian sponsor to invest 30% of capital in female, diverse founders; new fund-of-funds set to support emerging managers
Private Equity Trendspotter: Sponsors look for sure footing as market slowdown signals change in deals landscape
Aggregate buyout volume brings 2022 just 6% above pre-pandemic dealmaking, with a significant sentiment shift in H2 2022
The Bolt-Ons Digest – 14 December 2022
Unquoteтs selection of the latest add-ons, including CVC's Stark Group, Bridgepoint's Kereis, EQT's Open Systems, and more
EQT moves SHL Medical stake into long-term strategy fund
Family office ATHOS is co-investing in the deal, which sees the Swiss drug autoinjector group exit EQT VIII
Female Founders plans final close for EUR 20m debut fund in Q3 2023
Vienna-based VC investing in women-led teams held first close on EUR 12m in October
KKR buys Clinisupplies to build chronic care medical devices platform
GP installs former Atos CEO as chairman; deal is partial exit for Apax Partners' India-based Healthium
H2 turns to bilateral talks to get Optegra sale over the line, sources say
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
MidEuropa takes majority stake in Optegra
H2 Equity reinvests with minority share; sale saw interest from Partners, HIG, CapVest
Meanings primes second midcap fund for final close by Q2 2023
With a EUR 300m hard cap, the fund could complete its first investment by H1 2023
Eurazeo, GA-backed Doctolib weighs growth financing options
Appointment booking platform is holding preliminary talks for its next growth milestone
Women in PE: Triton's Meier-Kirner on deploying in times of crisis and resisting herd mentality
Pan-European sponsor aims to back undervalued businesses and those with structural tailwinds using learnings from past crises
Armonia exits Italy's BioDue in SBO to Riverside Europe
Sale of food supplement and medical devices group marks second exit from Armònia Italy Fund
CapMan to return to market for new growth fund in 2024
With EUR 100m-150m target, fundraising will launch after CapMan Growth II's full deployment
The Bolt-Ons Digest – 11 November 2022
Unquote’s selection of the latest add-ons including Hg and ICG's Iris, Inflexion's THE, Bain's House of HR and more
Ardian reinvests in Neopharmed alongside NB Renaissance
French GP will move stake from fund VI to VII; additional capital allows for European M&A
SHS exits minority stake Blazejewski Medi-Tech
GP has sold its 24.9% stake in German endoscopy medtech company to peer Erbe two years after investing
Triton's Pharmanovia tipped as 2023 sale candidate
Exit of specialty pharma group to another PE, minority stake sale with view to IPO on the cards
Nordic exits The Binding Site to trade in 'best ever' deal
GP to reap for 19x money in sale of specialty diagnostics group after 11 years, source says; Five Arrows also exits
Abris Capital 'confident' about new fundraise in 2023
Polish GP reinforces its ESG pitch and sees opportunities in rebuilding Ukraine
CVC discards Mehiläinen exit options, focuses on growth
GP bought the Finland-based healthcare service provider in EUR 1.8bn SBO from KKR in 2018